Summary

Oxygen Concentrator Market Summary

The global oxygen concentrator market size was estimated at USD 4.85 billion in 2024 and is projected to reach USD 8.31 billion by 2033, growing at a CAGR of 6.4% from 2025 to 2033. This is attributed to the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, coupled with the increasing launch of technologically advanced devices.

According to the Global Impact of Respiratory Disease study, around 200 million people suffer from COPD globally, resulting in 3.2 million deaths every year. Moreover, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in the U.S. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators. In addition, rising healthcare spending is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators. According to a Cleveland Clinic article in the U.S, over 1.5 million people rely on supplemental oxygen therapy, using devices such as oxygen tanks and concentrators.

Regional governments offer reimbursement policies that cover the cost of POCs for patients with respiratory illnesses. For instance, according to Inogen's 10K form document for the fiscal year ending December 31, 2021, the international market (excluding the U.S.) is attractive for oxygen concentrators due to favorable reimbursement policies in certain countries such as the UK and France. In these countries, portable oxygen concentrators receive more favorable reimbursement than in the U.S.

Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.

COVID-19 had a limited positive impact on the market, driving increased demand for technologically advanced and cost-effective oxygen concentrators. For example, UNICEF distributed 62,046 concentrators to 104 nations worldwide in July 2021, with approximately 12,788 concentrators sourced from a Chinese trade company. Growing need for emergency treatment and prolonged care for lung diseases in children and adults further propels the industry.

Global Oxygen Concentrator Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oxygen concentrator market report based on product, application, technology, and region:


• Products Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
• Portable Oxygen Concentrators
o New Purchase
o Rentals
• Fixed Oxygen Concentrators
o New Purchase
o Rentals
• Application Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
• Home Care
• Non- Home Care
• Technology Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
• Continuous Flow
• Pulse Flow
• Regional Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Sweden
o Denmark
o Norway
• Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Products
1.2.2. Application
1.2.3. Technology
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
3.2.1.2. Growing adoption of home healthcare
3.2.1.3. Technological advancements in oxygen concentrators
3.2.1.4. Launch of new generation products and increasing business expansion
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with oxygen concentrators
3.2.2.2. Increasing Product Recalls
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Oxygen concentrator Market: Products Estimates & Trend Analysis
4.1. Products Segment Dashboard
4.2. Products Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Products, 2021 to 2033 (USD Million, Unit Volume 000')
4.4. Portable Oxygen Concentrators
4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.2. Market estimates and forecast, 2021 to 2033 (Unit Volume 000')
4.4.3. New Purchase
4.4.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.4. Rentals
4.4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.5. Fixed Oxygen Concentrators
4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.5.2. Market estimates and forecast, 2021 to 2033 (Unit Volume 000')
4.5.3. New Purchase
4.5.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.5.4. Rentals
4.5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 5. Oxygen concentrator Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Application Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Home Care
5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.5. Non-Home Care
5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 6. Oxygen concentrator Market: Technology Estimates & Trend Analysis
6.1. Technology Segment Dashboard
6.2. Technology Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Continuous flow
6.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
6.5. Pulse Flow
6.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 7. Oxygen Concentrator Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market: Key Takeaways
7.3. North America
7.3.1. North America Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.3. Key country dynamic
7.3.3.1. Regulatory framework/Reimbursement Scenario
7.3.3.2. Competitive insights
7.3.3.3. U.S. Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.3.4. Canada
7.3.4.1. Key country dynamic
7.3.4.2. Regulatory framework/Reimbursement Scenario
7.3.4.3. Competitive insights
7.3.4.4. Canada Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.3.5. Mexico
7.3.5.1. Key country dynamic
7.3.5.2. Regulatory framework/Reimbursement Scenario
7.3.5.3. Competitive insights
7.3.5.4. Mexico Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4. Europe
7.4.1. Europe Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework/Reimbursement Scenario
7.4.2.3. Competitive insights
7.4.2.4. Germany Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.3. UK
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework/Reimbursement Scenario
7.4.3.3. Competitive insights
7.4.3.4. UK Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.4. France
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework/Reimbursement Scenario
7.4.4.3. Competitive insights
7.4.4.4. France Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.5. Italy
7.4.5.1. Key country dynamic
7.4.5.2. Regulatory framework/Reimbursement Scenario
7.4.5.3. Competitive insights
7.4.5.4. Italy Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.6. Spain
7.4.6.1. Key country dynamic
7.4.6.2. Regulatory framework/Reimbursement Scenario
7.4.6.3. Competitive insights
7.4.6.4. Spain Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.7. Denmark
7.4.7.1. Key country dynamic
7.4.7.2. Regulatory framework/Reimbursement Scenario
7.4.7.3. Competitive insights
7.4.7.4. Denmark Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.8. Sweden
7.4.8.1. Key country dynamic
7.4.8.2. Regulatory framework/Reimbursement Scenario
7.4.8.3. Competitive insights
7.4.8.4. Sweden Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.4.9. Norway
7.4.9.1. Key country dynamic
7.4.9.2. Regulatory framework/Reimbursement Scenario
7.4.9.3. Competitive insights
7.4.9.4. Norway Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5. Asia Pacific
7.5.1. Asia Pacific Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.2. Japan
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework/Reimbursement Scenario
7.5.2.3. Competitive insights
7.5.2.4. Japan Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.3. China
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework/Reimbursement Scenario
7.5.3.3. Competitive insights
7.5.3.4. China Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.4. India
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework/Reimbursement Scenario
7.5.4.3. Competitive insights
7.5.4.4. India Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.5. South Korea
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework/Reimbursement Scenario
7.5.5.3. Competitive insights
7.5.5.4. South Korea Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.6. Australia
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework/Reimbursement Scenario
7.5.6.3. Competitive insights
7.5.6.4. Australia Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.5.7. Thailand
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework/Reimbursement Scenario
7.5.7.3. Competitive insights
7.5.7.4. Thailand Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.6. Latin America
7.6.1. Latin America Oxygen Concentrator Market Estimates and Forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.6.2. Brazil
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework/Reimbursement Scenario
7.6.2.3. Competitive insights
7.6.2.4. Brazil Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.6.3. Argentina
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework/Reimbursement Scenario
7.6.3.3. Competitive insights
7.6.3.4. Argentina Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.7. MEA
7.7.1. MEA Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.7.2. South Africa
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework/Reimbursement Scenario
7.7.2.3. Competitive insights
7.7.2.4. South Africa Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework/Reimbursement Scenario
7.7.3.3. Competitive insights
7.7.3.4. Saudi Arabia Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.7.4. UAE
7.7.4.1. Key country dynamic
7.7.4.2. Regulatory framework/Reimbursement Scenario
7.7.4.3. Competitive insights
7.7.4.4. UAE Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
7.7.5. Kuwait
7.7.5.1. Key country dynamic
7.7.5.2. Regulatory framework/Reimbursement Scenario
7.7.5.3. Competitive insights
7.7.5.4. Kuwait Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million) (Unit Volume 000')
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Share Analysis (2021-2024), at oxygen concentrators
8.2.1. Portable Oxygen Concentrators (Value USD Million)
8.2.2. Fixed Oxygen Concentrators (Value USD Million)
8.3. Volume Analysis with ASP Trends (2021-2024) at oxygen concentrators
8.3.1. Portable Oxygen Concentrators (Unit Volume 000')
8.3.2. Fixed Oxygen Concentrators (Unit Volume 000')
8.4. Company Categorization
8.5. Strategy Mapping
8.6. Company Profiles/Listing
8.6.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
8.6.1.1. Overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. GF Health Products, Inc.
8.6.2.1. Overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. MedaCure Inc.
8.6.3.1. Overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Nidek Medical Products, Inc
8.6.4.1. Overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. O2 Concepts
8.6.5.1. Overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. React Health
8.6.6.1. Overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. CAIRE Inc. (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
8.6.7.1. Overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. DeVilbiss Healthcare (a subsidiary of Drive Medical)
8.6.8.1. Overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. GCE Group
8.6.9.1. Overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Compass Health Brands
8.6.10.1. Overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Inogen, Inc.
8.6.11.1. Overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
8.6.12. Belluscura
8.6.12.1. Overview
8.6.12.2. Financial performance
8.6.12.3. Product benchmarking
8.6.12.4. Strategic initiatives
8.6.13. Hoyo Scitech Co., Ltd.
8.6.13.1. Overview
8.6.13.2. Financial performance
8.6.13.3. Product benchmarking
8.6.13.4. Strategic initiatives
8.6.14. BPL Medical Technologies
8.6.14.1. Overview
8.6.14.2. Financial performance
8.6.14.3. Product benchmarking
8.6.14.4. Strategic initiatives
8.6.15. XNUO INTERNATIONAL GROUP (USA) HOLDING
8.6.15.1. Overview
8.6.15.2. Financial performance
8.6.15.3. Product benchmarking
8.6.15.4. Strategic initiatives
8.6.16. Teijin Limited
8.6.16.1. Overview
8.6.16.2. Financial performance
8.6.16.3. Product benchmarking
8.6.16.4. Strategic initiatives
8.6.17. BESCO MEDICAL LIMITED
8.6.17.1. Overview
8.6.17.2. Financial performance
8.6.17.3. Product benchmarking
8.6.17.4. Strategic initiatives
8.6.18. Oxymed India
8.6.18.1. Overview
8.6.18.2. Financial performance
8.6.18.3. Product benchmarking
8.6.18.4. Strategic initiatives
8.6.19. KALSTEIN FRANCE
8.6.19.1. Overview
8.6.19.2. Financial performance
8.6.19.3. Product benchmarking
8.6.19.4. Strategic initiatives
8.6.20. Foshan Keyhub Electronic Industries Co.,Ltd.
8.6.20.1. Overview
8.6.20.2. Financial performance
8.6.20.3. Product benchmarking
8.6.20.4. Strategic initiatives